OrbiMed’s Connecture, Inc. CNXR Stock Holding History

OrbiMed’s Portfolio CNXR Stock Details CNXR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,740,000	Closed	-$4.45M	–	152
2016 Q1	$4.45M	Hold	1,740,000	–	–	0.05%	118
2015 Q4	$6.28M	Hold	1,740,000	–	–	0.06%	105
2015 Q3	$7.93M	Hold	1,740,000	–	–	0.08%	99
2015 Q2	$18.4M	Hold	1,740,000	–	–	0.15%	86
2015 Q1	$18M	Buy	1,740,000 +1,437,700	+476%	+$13.3M	0.15%	83
2014 Q4	$2.72M	Buy	+302,300	New	+$2.71M	0.03%	120

Other funds holding CNXR

TAM

Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FPM

Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $15.9B AUM 53.4% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SIM

Spark Investment Management New York $51.2M AUM 87.14% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

OrbiMed's CNXR Position: Q2 2016 in Review

OrbiMed sold out of Connecture, Inc. (CNXR) in Q2 2016, closing a stake of 1,740,000 shares — an estimated $4.45M sold.

OrbiMed first reported a position in CNXR in Q4 2014 and held it in 6 quarters. The position peaked at $18.4M in Q2 2015. 43 funds tracked by Wall St. Rank hold CNXR as of Q2 2016.

OrbiMed reported no remaining Connecture, Inc. position as of Q2 2016 after selling out during the quarter.
OrbiMed sold 1,740,000 Connecture, Inc. shares in Q2 2016, an estimated $4.45M.
OrbiMed first reported a position in Connecture, Inc. in Q4 2014 and held it in 6 quarters.
OrbiMed's Connecture, Inc. position peaked at $18.4M in Q2 2015.
43 funds tracked by Wall St. Rank held Connecture, Inc. as of Q2 2016.

Based on OrbiMed's 13F filing for Q2 2016, filed 15 Aug 2016.